Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Most recent
Best match
7h
Gilead Sciences/Merck's Investigational Once-Weekly HIV Combo Therapy Shows Sustained Virus Suppression To 48 Weeks
Gilead Sciences and Merck presented Phase 2 results showing 94.2% viral suppression in HIV patients treated with islatravir and lenacapavir. Both weekly and daily treatments achieved comparable ...
7h
Solid Investment Potential: Buy Rating for Gilead Sciences Amid Positive Revenue Adjustments and Growth Commitment
TD Cowen analyst Tyler Van Buren has maintained their bullish stance on GILD stock, giving a Buy rating today. Tyler Van Buren’s rating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Liberty win first WNBA title
Ex-Iron Maiden singer dies
The Vessel to reopen
Minks released, 2 arrested
$1 million daily giveaway
SCOTUS rejects bid
Had multiple drugs in body?
SCOTUS rejects Cohen suit
Free OTC birth control plan
Helicopter hits radio tower
Gold hits fresh high
Albany State shooting
WWII code talker dies
New Mexico flash flooding
Faces new lawsuits
Oscar makes landfall
American activist Wair dies
Hezbollah assets targeted
NYC subway death trial
Oakland fire burns homes
Advance to World Series
Anti-missile system in Israel
Launches OneWeb mission
To roll out AI agents in Nov
Judge weighs Louisiana law
Out with ruptured Achilles
Bitcoin nears $70,000
Urges support for Ukraine
Rock & Roll HOF '24 class
Feedback